News

Jevtana, a microtubule inhibitor, in combination with prednisone, was approved based on results from the Phase 3 Tropic clinical study involving 755 patients with mHRPC previously treated with

Data from the phase III Tender study showed that, following three months’ treatment with RoActemra, 85% of patients achieved 30% improvement (JIA ACR30) in the signs and symptoms

FDA warned the consumers who had already faced adverse reactions from penicillin products and said that they are at risk of experiencing similar reactions from cloxacillin. This includes

In the trial, the difference was driven by a decrease in hemoglobin and/or hematocrit of defined or presumed GI origin. Pfizer claimed that Condor (Celecoxib vs Omeprazole and

Entecavir is an oral antiviral drug used in the treatment of Hepatitis-B infection. It works by inhibiting reverse transcription, DNA replication and transcription in the viral replication process.

Highmark will administer health insurance coverage to about 140,000 new members on behalf of PEBTF. Deborah Rice, executive vice president for health services at Highmark, said: “I believe

The effectiveness of Tasigna is based on major molecular response and cytogenetic response rates. The study is ongoing and further data will be required to determine long-term outcome.

As per the terms of collaboration agreement that signed on March 30, 2007, CanBas and Takeda’s wholly-owned subsidiary Millennium: The Takeda Oncology had jointly initiated Phase II trials

The court’s ruling narrowly defined several key phrases contained in Roquette’s patent claims, thereby dealing a significant blow to Roquette’s allegations of patent infringement. Reportedly, the court issued